Pneumatic Shoe Lacing Apparatus
This invention provides a pneumatic shoe lacing apparatus for the pneumatic lacing of shoe.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7323452 | Method for the accelerated in vivo removal of ethanol A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as catalysts or “pseudo” enzymes for the oxidation. These additives... | 01/29/2008 |
| 7264824 | Oral dosage form Oral dosage form for food and food supplement as well as dietetics comprising polyunsaturated acids in a xylose-hardened gelatine capsule with a retarded release time. ... | 09/04/2007 |
| 7265151 | Treatment of neurotic disorders Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder... | 09/04/2007 |
| 7189412 | Fenofibrate-containing composition A novel fenofibrate-containing composition having equivalent bioavailability, when compared to conventional capsules, is effective in reducing the size of the conventional capsule preparations. The fenofibrate-containing composition comprises the following formula: | 03/13/2007 |
| 7144585 | Cilostazol preparation Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility. Further, provided is a process for improving absorbability of a slight... | 12/05/2006 |
| 7128933 | Composition and method for the treatment of personal odors An orally ingestible composition for the treatment of external personal odors can include about 35% w/w to about 50% w/w of the essential oil of lavender, about 1% w/w to about 10% w/w of the essential oil of rosemary, about 1% w/w to about 10% w/w of the essential ... | 10/31/2006 |
| 7060263 | Super absorption Coenzyme Q An improved soft gelatin formulation and process methodology that increases single Coenzyme Q10 molecules presented to the absorption channels of the small intestines by providing medium chain triglycerides, Vitamin E and natural beta carotene to Coenzyme... | 06/13/2006 |
| 7041316 | Stable oral pharmaceutical dosage forms The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such a dosage forms, and to a method of gastric acid pump inhibition and p... | 05/09/2006 |
| 7022685 | Very high molecular weight β-glucans The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble β-glucan composition comprising β-glucan molecules having an average molecular weight of at least 1,0... | 04/04/2006 |
| 6998421 | Compounds and methods for inhibition of phospholipase Aand cyclooxygenase - 2 The present invention comprises a group of related lipid molecules, and methods for their use, that maybe used to treat inflammation and certain inflammation related diseases. The group of related lipid molecules are capable of inhibiting certain enzyme systems incl... | 02/14/2006 |
| 6967026 | Hard capsule A hard capsule which is made mainly of a polymer or copolymer obtained by polymerizing or copolymerizing at least one polymerizable vinyl monomer in the presence of polyvinyl alcohol and/or a derivative thereof. Unlike conventional hard capsules, this hard capsule c... | 11/22/2005 |
| 6964958 | Method of simultaneously treating sensory auditory gating deficit and associated psychosis in schizophrenia and bipolar disorder patients with mania Schizophrenia and bipolar disorders with mania may be treated by imidazenil or other benzodiazepine-3-carboxamide derviatives. ... | 11/15/2005 |
| 6960613 | Treatment of neurotic disorders Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder... | 11/01/2005 |
| 6893658 | Soft capsules An object of the present invention is to provide soft capsule formulations of active vitamins D, well-suited to practical production with easy discrimination of active ingredient levels, in which stability of the active vitamins D3 to light and heat is en... | 05/17/2005 |
| 6855733 | Formulation and manufacturing process for coenzyme Q10 soft gel capsules A soft gelatine capsule formulation for improved manufacturing of Coenzyme Q10, comprising Coenzyme Q10 in a thixatropic gelatine carrier capable of admixing without heating with Coenzyme Q10, and capable of keeping Coenzyme Q10 in suspension at ambient temperature.... | 02/15/2005 |
| 6833362 | Method and composition for the accelerated in vivo removal of ethanol A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or “pseudo” enzymes for the oxidation. Additives include the oxidant Nicotinami... | 12/21/2004 |
| 6827930 | System for attracting fish A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or natural bait. The system may further include an applicator for applying th... | 12/07/2004 |
| 6790495 | Method for manufacturing a shape body containing a starch, a homogenised mass containing starch and a device for manufacturing a soft capsule The invention relates to a method for manufacturing a starch-containing shape body and a homogenised, starch-containing mass and shape bodies manufactured therefrom. The method is carried out in a manner such that the value of the limiting viscosity index of the mas... | 09/14/2004 |
| 6726927 | Preparation of enteric pharmaceutical dosage forms for omerprazole and lansoprazole The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such a dosage forms, and to a method of gastric acid pump inhibition and p... | 04/27/2004 |
| 6723339 | Oil-free pharmaceutical compositions containing cyclosporin A The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A in a mixture with a surfactant of HLB value at least 10, substantially free of any oil and when a hydrophilic phase is present, the hydrophilic ph... | 04/20/2004 |
| 6710083 | Method of treating palmar and plantar fibromatosis A method of treating palmar and plantar fibromatosis is disclosed. The method includes administering to a patient of a therapeutically effective amount of a composition comprising 13-cis-retinoic acid. Preferably, the treatment method includes administering to a pat... | 03/23/2004 |
| 6706281 | Melt-extrusion multiparticulates A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an optional water-insoluble binder is disclosed. The particles have a length ... | 03/16/2004 |
| 6653339 | Method of treating irritable bowel syndrome The present invention is directed to a a method for the treatment of irritable bowel syndrome comprising the multiple daily pulse dosing of an immediate release formulation of the anti-muscarinic darifenacin. Dosing two or three times a day is particularl... | 11/25/2003 |
| 6623734 | Super absorption coenzyme Q10 A new soft gelatine formulation and process methodology is disclosed herein that increases single Coenzyme Q10 molecules presented to the absorption channels of the small intestines by providing medium chain triglycerides, Vitamin E, and natural beta caro... | 09/23/2003 |
| 6610673 | Solid dose forms containing bismuth A swallowable, solid dose form composition for treating upper gastrointestinal tract distress containing bismuth subsalicylate, carbonate or bicarbonate salt, disintegrating agent, anionic or nonionic surfactant, and microcrystalline cellulose is describe... | 08/26/2003 |
| 6592844 | Preparation of protein microspheres, films and coatings A process is described for preparing microspheres, films and coatings from protein or modified protein in which the protein product is stabilized by carrying out the preparation in the presence of an aqueous solution of at least one -hydroxy acid. ... | 07/15/2003 |
| 6569460 | Film-coated tablet for improved upper gastrointestinal tract safety A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidi... | 05/27/2003 |
| 6569452 | Pharmaceutical formulations in hydroxypropylmethylcellulose capsules An oral pharmaceutical formulation, which comprises, in a hydroxypropylmethylcellulose capsule, a camptothecin analogue dispersed or solubilized in a semi-solid matrix of a polyethyleneglycol with a molecular weight ranging from 400 to 20000.... | 05/27/2003 |
| 6555581 | Levothyroxine compositions and methods The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ing... | 04/29/2003 |
| 6544533 | 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging 10-Hydroxy-2-decenoic acid compounds, particularly the 10-hydroxydec-2-enoates, are well suited for promoting desquamation of human skin and/or stimulating epidermal renewal and thus combating intrinsic and/or extrinsic cutaneous aging.... | 04/08/2003 |
| 6509035 | Oral preparation of coenzyme a useful for lowering blood lipid and a method producing for same A coenzyme A oral preparation, a producing method and a use for treating hyperlipemia thereof are disclosed. The coenzyme A oral preparation of the present invention is tablet, capsule, powder, granule or microcapsule, which is consisted of coenzyme A, an... | 01/21/2003 |
| 6495596 | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2 The present invention comprises a group of related lipid molecules, and methods for their use, that maybe used to treat inflammation and certain inflammation related diseases. The group of related lipid molecules are capable of inhibiting certain enzyme s... | 12/17/2002 |
| 6475519 | Oil-free pharmaceutical compositions containing cyclosporin A The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A in a mixture with a surfactant of HLB value of at least 10, substantially free of any oil and when a hydrophilic phase is present, the ... | 11/05/2002 |
| 6468559 | Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods Oral dosage forms are provided for the administration of a bisphosphonic acid compound in the prevention and treatment of conditions involving calcium or phosphate metabolism, i.e., conditions associated with bone resorption such as osteoporosis, Paget's ... | 10/22/2002 |
| 6468509 | Sunscreen composition containing sol-gel microcapsules The present invention generally relates to safe and stable sunscreen compositions comprising of at least one sunscreen active ingredient in the form of an inert sol-gel microcapsules encapsulating ultraviolet absorbing compounds in any acceptable cosmetic... | 10/22/2002 |
| 6465018 | Dietary supplement for increasing energy, strength, and immune function A dietary supplement is provided that comprises creatine combined with ginseng and astragalus and, optionally, glutamine. The dietary supplement enhances the general energy boost and muscular strength increase achieved from the consumption of creatine alo... | 10/15/2002 |
| 6413494 | Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides A colonic drug delivery composition contains a first polysaccharide and a second polysaccharide wherein both polysaccharide are degradable by colonic enzymes and are mixed at a environmental pH of about 7 or above, without use of a cross-linking agent. A ... | 07/02/2002 |
| 6410050 | Cellulose capsule using mixed solution of pectin and glycerin and the manufacturing process thereof The present invention provides a cellulose capsule comprising the steps of: i) preparing a mixed solution of pectin and glycerin, ii) adding said mixed solution to solubilized cellulose aqueous solution, iii) adding a small amount of glacial acetic acid, ... | 06/25/2002 |
| 6403120 | Extended release formulation of venlafaxine hydrochloride This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be ... | 06/11/2002 |
| 6375981 | Modified starch as a replacement for gelatin in soft gel films and capsules Film-forming compositions are disclosed that can comprise, on a dry solids basis, 25 to 75 percent by weight of certain starch derivatives having a DE less than about 1, 25 to 75% plasticizer, and 0.1 to 15% hydrocolloid gum. The starch derviatives can be... | 04/23/2002 |